Correction: Moreal et al. Daptomycin dosing in clinical practice-fixed dose vs. weight-related dose: the role of therapeutic drug monitoring. Acad. Drug. 2026, 2, 8303
Academia Drug Development and Pharmacotherapy · 16.07.2026 · 2 (3)
DOI: 10.20935/acaddrug8429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academia Drug Development and Pharmacotherapy, online erschienen am 16.07.2026. Verfasst von Chiara Moreal und 4 weiteren Autor:innen.
Abstract (Originalsprache)
The error appears on page 3, in the section “Special populations and clinical scenarios”, where the following sentence is currently reported: “When creatinine clearance (CrCl) is 30 to
Zitieren
APA
Moreal, C., Angelini, J., Pai, M. P., Giuliano, S., & Tascini, C. (2026). Correction: Moreal et al. Daptomycin dosing in clinical practice-fixed dose vs. weight-related dose: the role of therapeutic drug monitoring. Acad. Drug. 2026, 2, 8303. Academia Drug Development and Pharmacotherapy, 2(3). https://doi.org/10.20935/acaddrug8429
Vancouver
Moreal C, Angelini J, Pai MP, Giuliano S, Tascini C. Correction: Moreal et al. Daptomycin dosing in clinical practice-fixed dose vs. weight-related dose: the role of therapeutic drug monitoring. Acad. Drug. 2026, 2, 8303. Academia Drug Development and Pharmacotherapy. 2026;2(3). doi:10.20935/acaddrug8429
BibTeX
@article{Moreal2026,
author = {Moreal, Chiara and Angelini, Jacopo and Pai, Manjunath P. and Giuliano, Simone and Tascini, Carlo},
title = {Correction: Moreal et al. Daptomycin dosing in clinical practice-fixed dose vs. weight-related dose: the role of therapeutic drug monitoring. Acad. Drug. 2026, 2, 8303},
journal = {Academia Drug Development and Pharmacotherapy},
year = {2026},
volume = {2},
number = {3},
doi = {10.20935/acaddrug8429}
}
EUVIMED